Prelude Therapeutics, Inc. (PRLD)
3.23
-0.09
(-2.71%)
USD |
NASDAQ |
Oct 16, 13:22
Prelude Therapeutics SG&A Expense (TTM) : 20.39M for June 30, 2026
SG&A Expense (TTM) Chart
Historical SG&A Expense (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 20.39M |
| March 31, 2026 | 21.77M |
| December 31, 2025 | 22.41M |
| September 30, 2025 | 23.62M |
| June 30, 2025 | 26.33M |
| March 31, 2025 | 27.58M |
| December 31, 2024 | 28.72M |
| September 30, 2024 | 29.56M |
| June 30, 2024 | 28.76M |
| March 31, 2024 | 28.54M |
| December 31, 2023 | 28.88M |
| September 30, 2023 | 29.35M |
| June 30, 2023 | 29.75M |
| March 31, 2023 | 30.46M |
| Date | Value |
|---|---|
| December 31, 2022 | 30.65M |
| September 30, 2022 | 30.97M |
| June 30, 2022 | 31.56M |
| March 31, 2022 | 28.93M |
| December 31, 2021 | 26.96M |
| September 30, 2021 | 24.00M |
| June 30, 2021 | 18.74M |
| March 31, 2021 | 14.88M |
| December 31, 2020 | 10.59M |
| September 30, 2020 | 6.958M |
| June 30, 2020 | 5.501M |
| March 31, 2020 | 3.841M |
| December 31, 2019 | 2.64M |
| September 30, 2019 | 1.394M |
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Q32 Bio, Inc. | 17.93M |
| Intellia Therapeutics, Inc. | 136.25M |
| Twist Bioscience Corp. | 290.29M |
| Beam Therapeutics, Inc. | 125.40M |
| Revolution Medicines, Inc. | 330.91M |